New Erectile Dysfunction Pill: What Trials in 84 Men Showed

Another Erectile Dysfunction Pill — But Does It Work?

Imagine: you take a pill, wait for the effect, and after half an hour nothing happens. Familiar? Scientists from China decided to test a new drug called simenafil — it is supposed to help with erectile dysfunction. The study was published in a medical journal, but the results turned out to be not as rosy as one would hope.

What Was Actually Done

The trial involved 84 men aged 18 to 65 with mild to moderate erectile dysfunction lasting at least six months. Each was given either a dummy (placebo) or simenafil at different doses — 2.5 mg, 5 mg, or 10 mg. The administration was blinded: neither the doctor nor the patient knew what was in the pill. There was a break of at least 5 days between doses.

To measure the effect, a special device was used — Rigiscan. It is placed on the penis and records how hard it becomes while watching an erotic video. The scientists looked at how long rigidity was maintained at least 60% of maximum.

What the Numbers Showed

In the first group (42 men), when taking 2.5 mg, the duration of rigidity at the tip increased by 3.1 minutes, and at the base — by 8.3 minutes compared to placebo. At a dose of 5 mg — by 3.7 and 8.5 minutes, respectively. In the second group (also 42 men), the 10 mg dose gave an increase in rigidity at the base by 5.9 minutes. But here's the catch: for some doses and sites (e.g., 5 mg at the tip or 10 mg at the tip), the difference from placebo was statistically insignificant — that is, it could be due to chance.

What This Means for You

If you have tried sildenafil (Viagra) or tadalafil, you know: they work for many, but not for everyone and not always perfectly. Simenafil is a new drug from the same group (PDE5 inhibitors). The trial showed that it works in principle, but the effect is modest: a few minutes of additional rigidity. This does not mean the drug is useless — it's just that its effectiveness is not yet impressive. Scientists believe it is worth studying further.

Should You Rush for a Prescription?

No. This is only the second phase of clinical trials — it's still far from pharmacies. The study is short, the number of participants is small, and the results for different doses are contradictory. If you have erection problems, do not expect a miracle from a new pill. It is better to discuss with your doctor already proven options: sildenafil, tadalafil, vardenafil. They have been studied thoroughly.

The Main Conclusion

Simenafil may become another tool in the arsenal of urologists, but it is too early to talk about a breakthrough. Trials are ongoing, and perhaps in a few years we will see more convincing data. For now, do not fall for loud headlines about a "new Viagra." Healthy sleep, exercise, and quitting smoking work no worse, and sometimes better, than any pill.